BUPROPION TABLET, EXTENDED RELEASE [CADILA HEALTHCARE LIMITED]

BUPROPION TABLET, EXTENDED RELEASE [CADILA HEALTHCARE LIMITED]
PDF | XML

NDC 65841-780-05, 65841-780-06, 65841-780-10, 65841-780-16, 65841-836-05, 65841-836-06, 65841-836-10, 65841-836-16
Set ID 78d34aad-9d4f-48c4-91eb-536e31c6b6c9
Category HUMAN PRESCRIPTION DRUG LABEL
Packager Cadila Healthcare Limited
Generic Name
Product Class Aminoketone
Product Number
Application Number ANDA201567
  • MEDICATION GUIDE

    Manufactured by:

    Cadila Healthcare Ltd.

    India.

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 65841-780-05

    Bupropion Hydrochloride Extended-release Tablets USP (XL), 300 mg

    500 Tablets

    Rx only

    Bupropion hydrochloride extended-release tablets, USP (XL)

    NDC 65841-836-05

    Bupropion Hydrochloride Extended-release Tablets USP (XL), 150 mg

    500 Tablets

    Rx only

    label
  • INGREDIENTS AND APPEARANCE
    BUPROPION 
    bupropion tablet, extended release
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:65841-780
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BUPROPION HYDROCHLORIDE (UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) BUPROPION HYDROCHLORIDE300 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    METHACRYLIC ACID (UNII: 1CS02G8656)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    POVIDONE (UNII: FZ989GH94E)  
    ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SHELLAC (UNII: 46N107B71O)  
    AMMONIA (UNII: 5138Q19F1X)  
    Product Characteristics
    ColorYELLOW (CREAMY WHITE TO PALE YELLOW) Scoreno score
    ShapeROUND (ROUND) Size9mm
    FlavorImprint Code 354
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65841-780-0630 in 1 BOTTLE; Type 0: Not a Combination Product02/15/2014
    2NDC:65841-780-1690 in 1 BOTTLE; Type 0: Not a Combination Product02/15/2014
    3NDC:65841-780-05500 in 1 BOTTLE; Type 0: Not a Combination Product02/15/2014
    4NDC:65841-780-101000 in 1 BOTTLE; Type 0: Not a Combination Product02/15/2014
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20156702/15/2014
    BUPROPION 
    bupropion tablet, extended release
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:65841-836
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BUPROPION HYDROCHLORIDE (UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) BUPROPION HYDROCHLORIDE150 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    METHACRYLIC ACID (UNII: 1CS02G8656)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    POVIDONE (UNII: FZ989GH94E)  
    ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SHELLAC (UNII: 46N107B71O)  
    AMMONIA (UNII: 5138Q19F1X)  
    Product Characteristics
    ColorYELLOW (CREAMY WHITE TO PALE YELLOW) Scoreno score
    ShapeROUND (ROUND) Size8mm
    FlavorImprint Code 353
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65841-836-0630 in 1 BOTTLE; Type 0: Not a Combination Product08/02/2018
    2NDC:65841-836-1690 in 1 BOTTLE; Type 0: Not a Combination Product08/02/2018
    3NDC:65841-836-05500 in 1 BOTTLE; Type 0: Not a Combination Product08/02/2018
    4NDC:65841-836-101000 in 1 BOTTLE; Type 0: Not a Combination Product08/02/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20156708/02/2018
    Labeler - Cadila Healthcare Limited (918596198)
    Registrant - Cadila Healthcare Limited (918596198)
    Establishment
    NameAddressID/FEIBusiness Operations
    Cadila Healthcare Limited918596198ANALYSIS(65841-780, 65841-836) , MANUFACTURE(65841-780, 65841-836)

Related Drugs